Search results
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival
Barrons.com· 5 days agoPfizer disclosed on May 7 that a child participating in another...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 6 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 1 day agoThe state of Kansas has reportedly filed a lawsuit against pharmaceutical giant Pfizer, Inc. PFE, accusing the company of violating consumer protection laws related to its ...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 2 days agoPfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock was trading at $52 in early June 2022, just before ...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 1 day ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 2 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open
Barrons.com· 5 days agoThe drug company Pfizer said a gene therapy it is testing failed to improve motor function in boys...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...